Viela Bio Inc (NASDAQ:VIE)
North American company
Share Price Chart
- Chart currently unavailable -
Market Info - VIE
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - VIE
- Market Cap$1.979bn
- SymbolNASDAQ:VIE
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINUS9266131005
Company Profile
Viela Bio Inc is a clinical-stage biotechnology company engaged in developing and commercializing transformative treatments for severe inflammation and autoimmune diseases. Its product inebilizumab, is a humanized monoclonal antibody, designed to target CD19, a molecule expressed on the surface of a broad range of immune system B cells.
Latest VIE news
Currently there for this company. Visit our news hub for other news .